Clinical Trial Update: A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy

View source ↗

Summary

This document reports an update on a clinical trial testing iptacopan in Korean patients with Paroxysmal Nocturnal Hemoglobinuria or C3 glomerulopathy; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• C3 Glomerulopathy
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy | Status: NOT_YET_RECRUITING